Hazra M. A rational pharmacovigilance safety appraisal of topical pefloxacin 0.3% ophthalmological drops in bacterial conjunctivitis, in global multi-centre tertiary care hospitals. Int J Basic Clin Pharmacol [Internet]. 2022 Jul. 1 [cited 2025 Oct. 23];11(4):302-7. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/5009